Tirzepatide
Tirzepatide is supplied for GIP and GLP-1 receptor pathway research in documented laboratory settings. Supplied strictly for laboratory and educational research. Not for human or veterinary use.
Vial amount
Purchase option
Checkout includes a research-use attestation. Materials are supplied only for laboratory and educational research.
Tirzepatide in research
Tirzepatide is supplied for GIP and GLP-1 receptor pathway research in documented laboratory settings.
Metabolic signaling and receptor pathway research, framed for bench context only.
Bench context
Supplied as a research-grade reference material for documented laboratory and educational research workflows.
Available amounts
Select from the stocked vial amounts for Tirzepatide before adding the material to cart.
Claims discipline
No protocol instructions, no dosing, no medical advice, and no therapeutic or human-use promises.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not a drug or supplement.
As listed by the supplier in BioRegen's ordering system, shown here exactly as written for transparency. This is the vendor's own description, not independently verified, edited, or endorsed by BioRegen, and is not a BioRegen claim of any effect.
10mg
Disclaimer: All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Overview:
Tirzepatide is a synthetic dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, designed to target multiple pathways for metabolic regulation. With its unique mechanism of action, Tirzepatide is a powerful research tool for studying metabolic health, glucose regulation, and weight management.
Key Features:
- Dual Receptor Activation: Activates both GIP and GLP-1 receptors for enhanced metabolic effects.
- Research Focused: Ideal for studies exploring glucose homeostasis, appetite regulation, and fat metabolism.
- High Purity: Supplied as a lyophilized powder with >99% purity for consistent, reliable research results.
- Convenient Packaging: Provided in a sterile, sealed vial, ready for laboratory preparation.
Scientific Applications: Tirzepatide has demonstrated potential in research focusing on:
- Weight Management: Investigation of mechanisms leading to reduced appetite and enhanced fat oxidation.
- Glucose Control: Studies on insulin sensitivity and glucose regulation in metabolic disorders.
- Cardiovascular Health: Exploration of its effects on lipid profiles and inflammation markers.
- Metabolic Syndrome: Research on improving energy balance and reducing metabolic risk factors.
Mechanism of Action:
Tirzepatide uniquely combines GIP and GLP-1 receptor activation to improve insulin secretion, suppress glucagon levels, and regulate appetite. This dual action enables researchers to explore its multifaceted effects on glucose metabolism, body weight, and overall metabolic health.
Tirzepatide is primarily studied for its effects on metabolic regulation, particularly in the context of type 2 diabetes, weight management, and related conditions. However, some researchers speculate about its anti-aging potential due to its broader effects on metabolic and systemic health. Here's why it might be considered relevant to anti-aging research and other potential human benefits:
Why Tirzepatide is Linked to Anti-Aging
- Metabolic Optimization and Longevity:
- Improved Glucose Regulation: Chronic hyperglycemia and insulin resistance are significant contributors to cellular aging and age-related diseases. Tirzepatide's ability to enhance insulin sensitivity and reduce glucose variability may indirectly mitigate these aging factors.
- Reduction in Inflammation: Research suggests that GLP-1 receptor agonists (and possibly GIP activity) can reduce systemic inflammation, a key driver of aging (inflammaging). By lowering inflammation markers, Tirzepatide may support overall cellular health.
- Weight Loss and Fat Reduction: Obesity is associated with accelerated aging due to oxidative stress, chronic inflammation, and metabolic strain. Tirzepatide’s ability to promote fat loss could improve overall longevity.
- Improved Cardiovascular Health:
- Studies indicate that Tirzepatide may improve lipid profiles, reduce atherosclerosis, and lower blood pressure. These cardiovascular benefits align with goals in anti-aging research, as heart disease is a leading cause of death in older adults.
- Potential Mitochondrial Benefits:
- Metabolic health is closely linked to mitochondrial function, a central player in aging processes. While not directly proven for Tirzepatide, improved glucose regulation and reduced metabolic stress may indirectly enhance mitochondrial efficiency and energy production, crucial for combating aging.
Other Human Benefits Being Researched
- Cognitive Health:
- Some GLP-1 receptor agonists (like Semaglutide) are being investigated for their potential neuroprotective effects in conditions like Alzheimer’s disease. Tirzepatide’s role in reducing systemic inflammation and improving metabolic health could indirectly benefit cognitive function.
- Insulin resistance has been linked to cognitive decline; Tirzepatide’s ability to regulate glucose and improve insulin sensitivity may support brain health.
- Liver Health:
- Tirzepatide is being studied for its impact on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Improved insulin sensitivity and weight loss could reduce liver fat accumulation and improve liver function.
- Polycystic Ovary Syndrome (PCOS):
- GLP-1 agonists have shown promise in managing symptoms of PCOS, including weight management and insulin resistance. Tirzepatide might offer similar benefits for women with this condition.
- Cardiovascular Risk Reduction:
- Early research shows potential in reducing markers associated with cardiovascular events, such as cholesterol levels, blood pressure, and inflammation. These effects could contribute to improved quality of life and reduced age-related cardiovascular risks.
- Cancer Prevention:
- Obesity and insulin resistance are linked to an increased risk of several cancers. By addressing these factors, Tirzepatide could theoretically play a role in cancer prevention, though this is an area requiring more research.
- Muscle Health:
- While not a direct focus of Tirzepatide, improved metabolic health and weight management may contribute to better muscle preservation and reduced sarcopenia (muscle loss associated with aging), especially in older populations.
What Does the Research Say?
The anti-aging interest in Tirzepatide is mostly speculative but grounded in its potential to:
- Reduce inflammation.
- Improve metabolic flexibility.
- Support cardiovascular and liver health.
- Indirectly influence other aging pathways.
It’s crucial to note that while these areas are exciting, Tirzepatide is not approved for anti-aging or non-diabetic metabolic purposes. Current research is in early stages for many of these applications.
Specifications:
- Molecular Formula: C225H348N48O68
- Molecular Weight: 4813.5 g/mol
- CAS Number: 2023788-19-2
- Vial Contents: Lyophilized powder (>99% purity)
- Storage Conditions: Store at -20°C for long-term stability. Once reconstituted, refrigerate and use promptly.
Important Note:
Tirzepatide is for research purposes only and is not approved for human or veterinary use. All product information is intended for educational purposes and is based on current scientific literature.
15mg
Disclaimer:
All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Overview:
Tirzepatide is a synthetic dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, designed to target multiple pathways for metabolic regulation. With its unique mechanism of action, Tirzepatide is a powerful research tool for studying metabolic health, glucose regulation, and weight management.
Key Features:
- Dual Receptor Activation: Activates both GIP and GLP-1 receptors for enhanced metabolic effects.
- Research Focused: Ideal for studies exploring glucose homeostasis, appetite regulation, and fat metabolism.
- High Purity: Supplied as a lyophilized powder with >99% purity for consistent, reliable research results.
- Convenient Packaging: Provided in a sterile, sealed vial, ready for laboratory preparation.
Scientific Applications: Tirzepatide has demonstrated potential in research focusing on:
- Weight Management: Investigation of mechanisms leading to reduced appetite and enhanced fat oxidation.
- Glucose Control: Studies on insulin sensitivity and glucose regulation in metabolic disorders.
- Cardiovascular Health: Exploration of its effects on lipid profiles and inflammation markers.
- Metabolic Syndrome: Research on improving energy balance and reducing metabolic risk factors.
Mechanism of Action:
Tirzepatide uniquely combines GIP and GLP-1 receptor activation to improve insulin secretion, suppress glucagon levels, and regulate appetite. This dual action enables researchers to explore its multifaceted effects on glucose metabolism, body weight, and overall metabolic health.
Tirzepatide is primarily studied for its effects on metabolic regulation, particularly in the context of type 2 diabetes, weight management, and related conditions. However, some researchers speculate about its anti-aging potential due to its broader effects on metabolic and systemic health. Here's why it might be considered relevant to anti-aging research and other potential human benefits:
Why Tirzepatide is Linked to Anti-Aging
- Metabolic Optimization and Longevity:
- Improved Glucose Regulation: Chronic hyperglycemia and insulin resistance are significant contributors to cellular aging and age-related diseases. Tirzepatide's ability to enhance insulin sensitivity and reduce glucose variability may indirectly mitigate these aging factors.
- Reduction in Inflammation: Research suggests that GLP-1 receptor agonists (and possibly GIP activity) can reduce systemic inflammation, a key driver of aging (inflammaging). By lowering inflammation markers, Tirzepatide may support overall cellular health.
- Weight Loss and Fat Reduction: Obesity is associated with accelerated aging due to oxidative stress, chronic inflammation, and metabolic strain. Tirzepatide’s ability to promote fat loss could improve overall longevity.
- Improved Cardiovascular Health:
- Studies indicate that Tirzepatide may improve lipid profiles, reduce atherosclerosis, and lower blood pressure. These cardiovascular benefits align with goals in anti-aging research, as heart disease is a leading cause of death in older adults.
- Potential Mitochondrial Benefits:
- Metabolic health is closely linked to mitochondrial function, a central player in aging processes. While not directly proven for Tirzepatide, improved glucose regulation and reduced metabolic stress may indirectly enhance mitochondrial efficiency and energy production, crucial for combating aging.
Other Human Benefits Being Researched
- Cognitive Health:
- Some GLP-1 receptor agonists (like Semaglutide) are being investigated for their potential neuroprotective effects in conditions like Alzheimer’s disease. Tirzepatide’s role in reducing systemic inflammation and improving metabolic health could indirectly benefit cognitive function.
- Insulin resistance has been linked to cognitive decline; Tirzepatide’s ability to regulate glucose and improve insulin sensitivity may support brain health.
- Liver Health:
- Tirzepatide is being studied for its impact on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Improved insulin sensitivity and weight loss could reduce liver fat accumulation and improve liver function.
- Polycystic Ovary Syndrome (PCOS):
- GLP-1 agonists have shown promise in managing symptoms of PCOS, including weight management and insulin resistance. Tirzepatide might offer similar benefits for women with this condition.
- Cardiovascular Risk Reduction:
- Early research shows potential in reducing markers associated with cardiovascular events, such as cholesterol levels, blood pressure, and inflammation. These effects could contribute to improved quality of life and reduced age-related cardiovascular risks.
- Cancer Prevention:
- Obesity and insulin resistance are linked to an increased risk of several cancers. By addressing these factors, Tirzepatide could theoretically play a role in cancer prevention, though this is an area requiring more research.
- Muscle Health:
- While not a direct focus of Tirzepatide, improved metabolic health and weight management may contribute to better muscle preservation and reduced sarcopenia (muscle loss associated with aging), especially in older populations.
What Does the Research Say?
The anti-aging interest in Tirzepatide is mostly speculative but grounded in its potential to:
- Reduce inflammation.
- Improve metabolic flexibility.
- Support cardiovascular and liver health.
- Indirectly influence other aging pathways.
It’s crucial to note that while these areas are exciting, Tirzepatide is not approved for anti-aging or non-diabetic metabolic purposes. Current research is in early stages for many of these applications.
Specifications:
- Molecular Formula: C225H348N48O68
- Molecular Weight: 4813.5 g/mol
- CAS Number: 2023788-19-2
- Vial Contents: Lyophilized powder (>99% purity)
- Storage Conditions: Store at -20°C for long-term stability. Once reconstituted, refrigerate and use promptly.
Important Note:
Tirzepatide is for research purposes only and is not approved for human or veterinary use. All product information is intended for educational purposes and is based on current scientific literature.
20mg
Disclaimer: All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Overview:
Tirzepatide is a synthetic dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, designed to target multiple pathways for metabolic regulation. With its unique mechanism of action, Tirzepatide is a powerful research tool for studying metabolic health, glucose regulation, and weight management.
Key Features:
- Dual Receptor Activation: Activates both GIP and GLP-1 receptors for enhanced metabolic effects.
- Research Focused: Ideal for studies exploring glucose homeostasis, appetite regulation, and fat metabolism.
- High Purity: Supplied as a lyophilized powder with >99% purity for consistent, reliable research results.
- Convenient Packaging: Provided in a sterile, sealed vial, ready for laboratory preparation.
Scientific Applications: Tirzepatide has demonstrated potential in research focusing on:
- Weight Management: Investigation of mechanisms leading to reduced appetite and enhanced fat oxidation.
- Glucose Control: Studies on insulin sensitivity and glucose regulation in metabolic disorders.
- Cardiovascular Health: Exploration of its effects on lipid profiles and inflammation markers.
- Metabolic Syndrome: Research on improving energy balance and reducing metabolic risk factors.
Mechanism of Action:
Tirzepatide uniquely combines GIP and GLP-1 receptor activation to improve insulin secretion, suppress glucagon levels, and regulate appetite. This dual action enables researchers to explore its multifaceted effects on glucose metabolism, body weight, and overall metabolic health.
Tirzepatide is primarily studied for its effects on metabolic regulation, particularly in the context of type 2 diabetes, weight management, and related conditions. However, some researchers speculate about its anti-aging potential due to its broader effects on metabolic and systemic health. Here's why it might be considered relevant to anti-aging research and other potential human benefits:
Why Tirzepatide is Linked to Anti-Aging
- Metabolic Optimization and Longevity:
- Improved Glucose Regulation: Chronic hyperglycemia and insulin resistance are significant contributors to cellular aging and age-related diseases. Tirzepatide's ability to enhance insulin sensitivity and reduce glucose variability may indirectly mitigate these aging factors.
- Reduction in Inflammation: Research suggests that GLP-1 receptor agonists (and possibly GIP activity) can reduce systemic inflammation, a key driver of aging (inflammaging). By lowering inflammation markers, Tirzepatide may support overall cellular health.
- Weight Loss and Fat Reduction: Obesity is associated with accelerated aging due to oxidative stress, chronic inflammation, and metabolic strain. Tirzepatide’s ability to promote fat loss could improve overall longevity.
- Improved Cardiovascular Health:
- Studies indicate that Tirzepatide may improve lipid profiles, reduce atherosclerosis, and lower blood pressure. These cardiovascular benefits align with goals in anti-aging research, as heart disease is a leading cause of death in older adults.
- Potential Mitochondrial Benefits:
- Metabolic health is closely linked to mitochondrial function, a central player in aging processes. While not directly proven for Tirzepatide, improved glucose regulation and reduced metabolic stress may indirectly enhance mitochondrial efficiency and energy production, crucial for combating aging.
Other Human Benefits Being Researched
- Cognitive Health:
- Some GLP-1 receptor agonists (like Semaglutide) are being investigated for their potential neuroprotective effects in conditions like Alzheimer’s disease. Tirzepatide’s role in reducing systemic inflammation and improving metabolic health could indirectly benefit cognitive function.
- Insulin resistance has been linked to cognitive decline; Tirzepatide’s ability to regulate glucose and improve insulin sensitivity may support brain health.
- Liver Health:
- Tirzepatide is being studied for its impact on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Improved insulin sensitivity and weight loss could reduce liver fat accumulation and improve liver function.
- Polycystic Ovary Syndrome (PCOS):
- GLP-1 agonists have shown promise in managing symptoms of PCOS, including weight management and insulin resistance. Tirzepatide might offer similar benefits for women with this condition.
- Cardiovascular Risk Reduction:
- Early research shows potential in reducing markers associated with cardiovascular events, such as cholesterol levels, blood pressure, and inflammation. These effects could contribute to improved quality of life and reduced age-related cardiovascular risks.
- Cancer Prevention:
- Obesity and insulin resistance are linked to an increased risk of several cancers. By addressing these factors, Tirzepatide could theoretically play a role in cancer prevention, though this is an area requiring more research.
- Muscle Health:
- While not a direct focus of Tirzepatide, improved metabolic health and weight management may contribute to better muscle preservation and reduced sarcopenia (muscle loss associated with aging), especially in older populations.
What Does the Research Say?
The anti-aging interest in Tirzepatide is mostly speculative but grounded in its potential to:
- Reduce inflammation.
- Improve metabolic flexibility.
- Support cardiovascular and liver health.
- Indirectly influence other aging pathways.
It’s crucial to note that while these areas are exciting, Tirzepatide is not approved for anti-aging or non-diabetic metabolic purposes. Current research is in early stages for many of these applications.
Specifications:
- Molecular Formula: C225H348N48O68
- Molecular Weight: 4813.5 g/mol
- CAS Number: 2023788-19-2
- Vial Contents: Lyophilized powder (>99% purity)
- Storage Conditions: Store at -20°C for long-term stability. Once reconstituted, refrigerate and use promptly.
Important Note:
Tirzepatide is for research purposes only and is not approved for human or veterinary use. All product information is intended for educational purposes and is based on current scientific literature.
30mg
Disclaimer: All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Overview:
Tirzepatide is a synthetic dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, designed to target multiple pathways for metabolic regulation. With its unique mechanism of action, Tirzepatide is a powerful research tool for studying metabolic health, glucose regulation, and weight management.
Key Features:
- Dual Receptor Activation: Activates both GIP and GLP-1 receptors for enhanced metabolic effects.
- Research Focused: Ideal for studies exploring glucose homeostasis, appetite regulation, and fat metabolism.
- High Purity: Supplied as a lyophilized powder with >99% purity for consistent, reliable research results.
- Convenient Packaging: Provided in a sterile, sealed vial, ready for laboratory preparation.
Scientific Applications: Tirzepatide has demonstrated potential in research focusing on:
- Weight Management: Investigation of mechanisms leading to reduced appetite and enhanced fat oxidation.
- Glucose Control: Studies on insulin sensitivity and glucose regulation in metabolic disorders.
- Cardiovascular Health: Exploration of its effects on lipid profiles and inflammation markers.
- Metabolic Syndrome: Research on improving energy balance and reducing metabolic risk factors.
Mechanism of Action:
Tirzepatide uniquely combines GIP and GLP-1 receptor activation to improve insulin secretion, suppress glucagon levels, and regulate appetite. This dual action enables researchers to explore its multifaceted effects on glucose metabolism, body weight, and overall metabolic health.
Tirzepatide is primarily studied for its effects on metabolic regulation, particularly in the context of type 2 diabetes, weight management, and related conditions. However, some researchers speculate about its anti-aging potential due to its broader effects on metabolic and systemic health. Here's why it might be considered relevant to anti-aging research and other potential human benefits:
Why Tirzepatide is Linked to Anti-Aging
- Metabolic Optimization and Longevity:
- Improved Glucose Regulation: Chronic hyperglycemia and insulin resistance are significant contributors to cellular aging and age-related diseases. Tirzepatide's ability to enhance insulin sensitivity and reduce glucose variability may indirectly mitigate these aging factors.
- Reduction in Inflammation: Research suggests that GLP-1 receptor agonists (and possibly GIP activity) can reduce systemic inflammation, a key driver of aging (inflammaging). By lowering inflammation markers, Tirzepatide may support overall cellular health.
- Weight Loss and Fat Reduction: Obesity is associated with accelerated aging due to oxidative stress, chronic inflammation, and metabolic strain. Tirzepatide’s ability to promote fat loss could improve overall longevity.
- Improved Cardiovascular Health:
- Studies indicate that Tirzepatide may improve lipid profiles, reduce atherosclerosis, and lower blood pressure. These cardiovascular benefits align with goals in anti-aging research, as heart disease is a leading cause of death in older adults.
- Potential Mitochondrial Benefits:
- Metabolic health is closely linked to mitochondrial function, a central player in aging processes. While not directly proven for Tirzepatide, improved glucose regulation and reduced metabolic stress may indirectly enhance mitochondrial efficiency and energy production, crucial for combating aging.
Other Human Benefits Being Researched
- Cognitive Health:
- Some GLP-1 receptor agonists (like Semaglutide) are being investigated for their potential neuroprotective effects in conditions like Alzheimer’s disease. Tirzepatide’s role in reducing systemic inflammation and improving metabolic health could indirectly benefit cognitive function.
- Insulin resistance has been linked to cognitive decline; Tirzepatide’s ability to regulate glucose and improve insulin sensitivity may support brain health.
- Liver Health:
- Tirzepatide is being studied for its impact on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Improved insulin sensitivity and weight loss could reduce liver fat accumulation and improve liver function.
- Polycystic Ovary Syndrome (PCOS):
- GLP-1 agonists have shown promise in managing symptoms of PCOS, including weight management and insulin resistance. Tirzepatide might offer similar benefits for women with this condition.
- Cardiovascular Risk Reduction:
- Early research shows potential in reducing markers associated with cardiovascular events, such as cholesterol levels, blood pressure, and inflammation. These effects could contribute to improved quality of life and reduced age-related cardiovascular risks.
- Cancer Prevention:
- Obesity and insulin resistance are linked to an increased risk of several cancers. By addressing these factors, Tirzepatide could theoretically play a role in cancer prevention, though this is an area requiring more research.
- Muscle Health:
- While not a direct focus of Tirzepatide, improved metabolic health and weight management may contribute to better muscle preservation and reduced sarcopenia (muscle loss associated with aging), especially in older populations.
What Does the Research Say?
The anti-aging interest in Tirzepatide is mostly speculative but grounded in its potential to:
- Reduce inflammation.
- Improve metabolic flexibility.
- Support cardiovascular and liver health.
- Indirectly influence other aging pathways.
It’s crucial to note that while these areas are exciting, Tirzepatide is not approved for anti-aging or non-diabetic metabolic purposes. Current research is in early stages for many of these applications.
Specifications:
- Molecular Formula: C225H348N48O68
- Molecular Weight: 4813.5 g/mol
- CAS Number: 2023788-19-2
- Vial Contents: Lyophilized powder (>99% purity)
- Storage Conditions: Store at -20°C for long-term stability. Once reconstituted, refrigerate and use promptly.
Important Note:
Tirzepatide is for research purposes only and is not approved for human or veterinary use. All product information is intended for educational purposes and is based on current scientific literature.
60mg
Disclaimer: All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Overview:
Tirzepatide is a synthetic dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, designed to target multiple pathways for metabolic regulation. With its unique mechanism of action, Tirzepatide is a powerful research tool for studying metabolic health, glucose regulation, and weight management.
Key Features:
- Dual Receptor Activation: Activates both GIP and GLP-1 receptors for enhanced metabolic effects.
- Research Focused: Ideal for studies exploring glucose homeostasis, appetite regulation, and fat metabolism.
- High Purity: Supplied as a lyophilized powder with >99% purity for consistent, reliable research results.
- Convenient Packaging: Provided in a sterile, sealed vial, ready for laboratory preparation.
Scientific Applications: Tirzepatide has demonstrated potential in research focusing on:
- Weight Management: Investigation of mechanisms leading to reduced appetite and enhanced fat oxidation.
- Glucose Control: Studies on insulin sensitivity and glucose regulation in metabolic disorders.
- Cardiovascular Health: Exploration of its effects on lipid profiles and inflammation markers.
- Metabolic Syndrome: Research on improving energy balance and reducing metabolic risk factors.
Mechanism of Action:
Tirzepatide uniquely combines GIP and GLP-1 receptor activation to improve insulin secretion, suppress glucagon levels, and regulate appetite. This dual action enables researchers to explore its multifaceted effects on glucose metabolism, body weight, and overall metabolic health.
Tirzepatide is primarily studied for its effects on metabolic regulation, particularly in the context of type 2 diabetes, weight management, and related conditions. However, some researchers speculate about its anti-aging potential due to its broader effects on metabolic and systemic health. Here's why it might be considered relevant to anti-aging research and other potential human benefits:
Why Tirzepatide is Linked to Anti-Aging
- Metabolic Optimization and Longevity:
- Improved Glucose Regulation: Chronic hyperglycemia and insulin resistance are significant contributors to cellular aging and age-related diseases. Tirzepatide's ability to enhance insulin sensitivity and reduce glucose variability may indirectly mitigate these aging factors.
- Reduction in Inflammation: Research suggests that GLP-1 receptor agonists (and possibly GIP activity) can reduce systemic inflammation, a key driver of aging (inflammaging). By lowering inflammation markers, Tirzepatide may support overall cellular health.
- Weight Loss and Fat Reduction: Obesity is associated with accelerated aging due to oxidative stress, chronic inflammation, and metabolic strain. Tirzepatide’s ability to promote fat loss could improve overall longevity.
- Improved Cardiovascular Health:
- Studies indicate that Tirzepatide may improve lipid profiles, reduce atherosclerosis, and lower blood pressure. These cardiovascular benefits align with goals in anti-aging research, as heart disease is a leading cause of death in older adults.
- Potential Mitochondrial Benefits:
- Metabolic health is closely linked to mitochondrial function, a central player in aging processes. While not directly proven for Tirzepatide, improved glucose regulation and reduced metabolic stress may indirectly enhance mitochondrial efficiency and energy production, crucial for combating aging.
Other Human Benefits Being Researched
- Cognitive Health:
- Some GLP-1 receptor agonists (like Semaglutide) are being investigated for their potential neuroprotective effects in conditions like Alzheimer’s disease. Tirzepatide’s role in reducing systemic inflammation and improving metabolic health could indirectly benefit cognitive function.
- Insulin resistance has been linked to cognitive decline; Tirzepatide’s ability to regulate glucose and improve insulin sensitivity may support brain health.
- Liver Health:
- Tirzepatide is being studied for its impact on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Improved insulin sensitivity and weight loss could reduce liver fat accumulation and improve liver function.
- Polycystic Ovary Syndrome (PCOS):
- GLP-1 agonists have shown promise in managing symptoms of PCOS, including weight management and insulin resistance. Tirzepatide might offer similar benefits for women with this condition.
- Cardiovascular Risk Reduction:
- Early research shows potential in reducing markers associated with cardiovascular events, such as cholesterol levels, blood pressure, and inflammation. These effects could contribute to improved quality of life and reduced age-related cardiovascular risks.
- Cancer Prevention:
- Obesity and insulin resistance are linked to an increased risk of several cancers. By addressing these factors, Tirzepatide could theoretically play a role in cancer prevention, though this is an area requiring more research.
- Muscle Health:
- While not a direct focus of Tirzepatide, improved metabolic health and weight management may contribute to better muscle preservation and reduced sarcopenia (muscle loss associated with aging), especially in older populations.
What Does the Research Say?
The anti-aging interest in Tirzepatide is mostly speculative but grounded in its potential to:
- Reduce inflammation.
- Improve metabolic flexibility.
- Support cardiovascular and liver health.
- Indirectly influence other aging pathways.
It’s crucial to note that while these areas are exciting, Tirzepatide is not approved for anti-aging or non-diabetic metabolic purposes. Current research is in early stages for many of these applications.
Specifications:
- Molecular Formula: C225H348N48O68
- Molecular Weight: 4813.5 g/mol
- CAS Number: 2023788-19-2
- Vial Contents: Lyophilized powder (>99% purity)
- Storage Conditions: Store at -20°C for long-term stability. Once reconstituted, refrigerate and use promptly.
Important Note:
Tirzepatide is for research purposes only and is not approved for human or veterinary use. All product information is intended for educational purposes and is based on current scientific literature.
The full research picture, clearly labeled
BioRegen reports the entire research landscape for this compound across four clearly separated tiers, strongest evidence first. Lower tiers, including community and anecdotal reports, are labeled as such and are not BioRegen claims.
Tirzepatide, a dual GIP and GLP-1 receptor agonist, was studied in the SURPASS trials (type 2 diabetes) and the SURMOUNT trials (chronic weight management). Investigators reported large reductions in body weight and glucose markers versus comparators. See for example Jastreboff AM, et al. (SURMOUNT-1), N Engl J Med 2022. These are investigator-reported trial findings.
Preclinical research characterized combined GIP and GLP-1 receptor engagement and the resulting metabolic signaling in cell and animal models.
Tirzepatide is widely discussed in media and weight-management communities under the brand names Mounjaro and Zepbound. That discussion is unverified anecdotal commentary, not controlled data, and not a BioRegen claim.
FDA-approved as a prescription medicine (Mounjaro for type 2 diabetes; Zepbound for chronic weight management). BioRegen supplies tirzepatide reference material strictly for laboratory and educational research, not for human use.
Tiers are evidence categories, not endorsements. Clinical and preclinical entries summarize third-party published research. Community and anecdotal entries are unverified reports discussed by others, not findings and not BioRegen claims. Nothing here is medical advice, and no compound is approved for human or veterinary use except where explicitly stated under Regulatory status.
What the published research says about Tirzepatide
This section reports on published research referenced in BioRegen's own research library. It is not a claim by BioRegen that the compound provides any benefit, and nothing here is medical advice.
- Rosenstock J, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet. 2021. https://doi.org/10.1016/S0140-6736(21)01324-6
- Nauck MA, D'Alessio DA. Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes. Cardiovasc Diabetol. 2022. https://doi.org/10.1186/s12933-022-01604-7